News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Tokai Pharmaceuticals To Present At The 34th Annual Cowen and Company Health Care Conference



2/24/2014 6:47:12 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Tokai Pharmaceuticals, Inc., a biopharmaceutical company focused on developing new treatments for prostate cancer and other hormonally driven cancers, today announced that Jodie Morrison, president and chief executive officer, will present an overview of the company and the interim Phase 2 data on its lead prostate cancer drug candidate galeterone at the 34th Annual Cowen Health Care Conference on Monday, March 3, 2014 at 2:00 p.m. (ET) in Boston.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES